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1. Introduction 
Polymorphonuclear leukocytes (PMN) of human 
peripheral blood have recently been shown to synthe- 
size the lipoxygenase products S-hydroxyeicosatetra- 
enoic (5OH-C20 :4), 15-hydroxyeicosatetraenoic ac d 
(15OHC204) and 5,12-dihydroxy-tetraenoic acid 
(5 ,I 2-diOHC20 :4) when incubated with arachidonic 
acid and ionophore A23 187 [ 1 ] (fig.1). The forma- 
tion of prostaglandins [2] and thromboxanes [3] 
under similar conditions has been reported. Human 
PMN have also been reported to produce slow reacting 
substance of anaphylaxis (SRS-A) when incubated 
with ionophore A23 187 and cystein [4]. 
SRS activity produced in mouse mastocytomas 
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Fig.1. Lipoxygenase pathways of arachidonate in human PMN. 
Dotted arrow tentative. 
Fig.2. 3-Amino-l-(m-(trfluoromethyl)-phenyl)-2-pyrazoline 
(BW-7550. 
was shown to have a structure which indicated that 
it might be formed from arachidonate via an epoxide 
intermediate (fig.1) [5,6]. These findings made it of 
interest o investigate the effect of a combined cyclo- 
oxygenase and lipoxygenase inhibitor on the forma- 
tion of SRS-A in human PMN. 
The compound used was BW-755C (3-amino-l- 
(m-(trifluoromethyl)-phenyl)-2-pyrazoline) (fig.2) 
which was reported to be an anti-inflammatory com- 
pound that inhibits cyclo-oxygenase aswell as lipoxy- 
genase in rat lung [7] and in horse platelets [8]. 
Thus, we have incubated human PMN with arach- 
idonic acid and ionophore A23 187, in the presence 
of BW-755 at different concentrations. The effects 
on the biosynthesis of the various metabolites have 
been investigated, using HPLC and bioassay tech- 
niques . 
2. Materials and methods 
2.1. Materials 
BW-755C was kindly provided by Dr F. Kuehl, 
Merck Inst. for Therapeutic Res., MI. Ionophore 
A23 187 was a kind gift from Dr R. L. Hamill, Eli 
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Lilly Res. Labs., IN and FPL 55712 was a kind gift 
from Fisons Ltd., Pharmaceut. Div., Loughborough. 
Arachidonic acid was purchased from Nu-Chek-Prep., 
MN and indomethacin from Sigma Chem. Co. MO. 
2.2. Cell preparation 
Human PMN were obtained from healthy donors 
who had not taken any drugs for the last 10 days. The 
cell suspension was prepared in accordance with [ 11. 
Briefly, the PMN were prepared by centrifugation to 
remove platelet-rich plasma, dextran sedimentation to 
separate white cells from red cells, ammoniumchloride 
lysis to remove traces of erythrocytes and finally 
gradient centrifugation in Lymphoprep to separate 
PMN from other white cells. The resultant cell suspen- 
sion contained mainly polymorphonuclear and 
eosinopholic granulocytes. 
For incubation the cells were suspended in 
Dulbecco’s PBS buffer (pH 7.4) (3.0-3.5 X 10’ 
cells/ml). 
2.3. Incubations 
PMN were preincubated for 2 min with or without 
BW-755C. All samples were also preincubated with 
indomethacin 5 X lo-’ M to inhibit the cyclo- 
oxygenase pathway. Arachidonic acid (1.5 X lO+ M) 
was added simultaneously with ionophore A23 187 
(5 X lo6 M). All substances added were dissolved in 
ethanol, the volume of which was <l% of the total 
incubation mixture. Incubation times were 45 s to 
10 min for samples subjected to SRS-bioassay, and 
4-10 min for those analysed for hydroxy-acids. 
2.4. SRS bioassay 
For SRS assay 1.5 ml aliquots of incubation mix- 
ture were filtered (Whatman GF/A) to remove whole 
cells and 0.5 ml of the filtrate was immediately added 
to a guinea-pig ileum strip bathed in a 7 ml cuvette 
with Tyrode’s solution containing atropine ( 10e6 M) 
and pyrilamine maleate (10 -6 M). Contractions were 
measured using a Grass force-displacement ransducer 
with a Grass Polygraph 79 C. To measure the inhib- 
itory effect of a given concentration of BW-755C, the 
average of the contraction amplitudes of two noninhib- 
ited incubations, added before and after the sample 
containing BW-755C, were taken as 100%. The 
amplitude of the incubation with inhibitor was 
expressed as a percentage of this mean. 
214 
2 5. Analysis of j-OH, 15-OH and 5,12-diOH-C20:4 
The incubation was stopped with 1.5 vol. methanol 
containing 5 pg PGB*, which was used as an internal 
standard through the purification. Lipids were extracted 
with diethyl-ether [ 1 ] and separated on a silicic acid 
column (1 g SiOs; Mallinkrodt Silicar, CC-4). The 
column was eluted with 30 ml hexane/diethyl ether, 
80/20 (v/v) followed by 30 ml ethylacetate. The 
ethylacetate eluate was evaporated and dissolved in 
methanol. Fractions of these samples were injected 
onto a high-pressure liquid chromatograph (HPLC), 
equipped with a reversed phase column (Nucleosil 
Cra, 5 pm-spherical, Macherey-Nagel Comp., Diiren). 
The column was eluted with methanol/water/acetic 
acid, 75/25/0.01 (v/v/v). The ultraviolet detector was 
set at 232 nm for monohydroxy acids and at 280 nm 
for dihydroxy acids and PGB?. The HPLC procedure 
was performed in accordance with [ 1 ] -where the 
identities of the peaks were determined. 
Metabolites were quantitated from the ratio of 
the corresponding HPLC peak areas, to the PGBz 
internal standard. 
3. Results 
The compound BW-755C inhibited formation of 
5-OH-C20:4 and 5,12-diOH-C20:4 in human PMN 
incubated with arachidonic acid and ionophore 
A23 187 with an Es,-, of 2-5 I.cg/ml. Formation of 
15-OH-C20:4 was inhibited with an K’s,, of 
80-90 fig/ml. At <50 pg BW-755C/ml the formation 
of 15-OH-C20:4 was increased, when compared to 
standard. 
Human PMN incubated with ionophore and arach- 
idonic acid also produced SRS activity (cells from 
most donors produced significant amounts of SRS 
when incubated with only arachidonic acid, but the 
quantities of SRS were in all cases markedly increased 
when ionophore was added simultaneously). Also the 
SRS formation was inhibited by BW-755C (Km = 
4-20 pg/ml) (fig.3). BW-755C itself did not inhibit 
contractions of the gut when given simultaneously 
with SRS to the ileum strip, which indicates that the 
compound did not exert its effect at the target-organ 
level. A corresponding amount of ionophore given 
directly to the gut gave a contraction about one tenth 
of the one produced by the incubation mixture. It also 
had a totally different character, and was not inhibited 
by FPL 55712 [9]. 
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Fig.3. Diagrams howing the effects of BW-755C on the 
Iipoxygenase products in human PMN. Abscissa values are 
clg BW-755C/ml. 
Evidence that the contractions of the guinea pig 
ileum were caused by SRS was suggested bythe insen- 
sitivity to histamine and acetylcholine antagonists, by 
the characteristic time-course ofcontractions produced, 
and by the antagonistic effect on the contraction by 
the SRS-A antagonist FPL 557 12 [9]. Prostaglandin 
and thromboxane formation in the PMN, were inhib- 
ited by indomethac~ at concentrations that did not 
affect formation of the hydroxy-compounds investi- 
gated. 
4. Discussion 
Pol~o~honuclear leukocytes have a number of 
functions including eneration of SRS. Cyclo- 
oxygenase and lipoxygenase metabolites of arach- 
idonic acid and other unsaturated fatty acids are 
thought o have a role in the inflammatory response, 
as mediators and regulators. 
Here we have found that the pyrazoline derivative 
BW-7SSC inhibits formation of 5-OH-C20:4,15-OH- 
C20:4,5.12-diOH-C20:4 and SRS in human PMN. 
It was shown in [5], that SRS activity obtained 
from mouse mastocytomas is a metabolite of arach- 
idonic acid. Our fmding that SRS formation and 
oxygenation at C-5 in human PMN, both are inhib- 
ited by BW-755C in similar dose-response patterns, 
indicates that a lipoxygenase product is also involved 
in the formation of SI$S in human cells. Additional 
studies are required to identify SRS from human 
leukocytes. 
Thus BW-755C might be an important ool for 
further studies on SRS formation, and the inflamma- 
tory response in human leukocytes. The results also 
indicate that lipoxygenase inhibitors might be of 
therapeutic value in the treatment of asthma. 
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